These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 19779864)

  • 1. Nuclear imaging of molecular processes in cancer.
    Torres Martin de Rosales R; Arstad E; Blower PJ
    Target Oncol; 2009 Sep; 4(3):183-97. PubMed ID: 19779864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).
    Shokeen M; Anderson CJ
    Acc Chem Res; 2009 Jul; 42(7):832-41. PubMed ID: 19530674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy.
    Witney TH; Blower PJ
    Cancer Imaging; 2021 Jan; 21(1):18. PubMed ID: 33516256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technologies for translational imaging using generators in oncology.
    Schechter NR; Yang DJ; Azhdarinia A; Chanda M
    Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):251-8. PubMed ID: 18221069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases.
    Okarvi SM
    Med Res Rev; 2004 May; 24(3):357-97. PubMed ID: 14994368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings.
    Follacchio GA; De Feo MS; De Vincentis G; Monteleone F; Liberatore M
    Curr Radiopharm; 2018; 11(1):22-33. PubMed ID: 29231149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerenkov luminescence imaging of medical isotopes.
    Ruggiero A; Holland JP; Lewis JS; Grimm J
    J Nucl Med; 2010 Jul; 51(7):1123-30. PubMed ID: 20554722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals.
    Bombardieri E; Coliva A; Maccauro M; Seregni E; Orunesu E; Chiti A; Lucignani G
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):3-15. PubMed ID: 20168282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted molecular imaging in oncology.
    Yang DJ; Kim EE; Inoue T
    Ann Nucl Med; 2006 Jan; 20(1):1-11. PubMed ID: 16485568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.
    Ting G; Chang CH; Wang HE; Lee TW
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20811605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applications.
    Pagani M; Stone-Elander S; Larsson SA
    Eur J Nucl Med; 1997 Oct; 24(10):1301-27. PubMed ID: 9323273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of radiopharmaceuticals in nuclear oncology.
    Denoyer D; Perek N; Le Jeune N; Dubois F
    Curr Cancer Drug Targets; 2006 May; 6(3):181-96. PubMed ID: 16712456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Imaging of Glucose Metabolism: Beyond
    Feng H; Wang X; Chen J; Cui J; Gao T; Gao Y; Zeng W
    Contrast Media Mol Imaging; 2019; 2019():7954854. PubMed ID: 31049045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer.
    Hamoudeh M; Kamleh MA; Diab R; Fessi H
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1329-46. PubMed ID: 18562040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions.
    Farzin L; Sheibani S; Moassesi ME; Shamsipur M
    J Biomed Mater Res A; 2019 Jan; 107(1):251-285. PubMed ID: 30358098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future direction of renal positron emission tomography.
    Szabo Z; Xia J; Mathews WB; Brown PR
    Semin Nucl Med; 2006 Jan; 36(1):36-50. PubMed ID: 16356795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operational nuclear research reactors in the Asia-Pacific with potential for medical radionuclide production.
    Tan HY; Wong YH; Kasbollah A; Md Shah MN; Perkins AC; Yeong CH
    Nucl Med Commun; 2023 Apr; 44(4):227-243. PubMed ID: 36808108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioactive Transition Metals for Imaging and Therapy.
    Boros E; Packard AB
    Chem Rev; 2019 Jan; 119(2):870-901. PubMed ID: 30299088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.